Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent HER-Targeted Therapy
Grazia Arpino(Children's Cancer Center), Rachel Schiff(Baylor College of Medicine)
Cited by 189
Related Papers
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation
|Breast Cancer Research|2011|283
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
|Breast Cancer Research|2011|162